NCT04822688Completed
Analysis of Cell Count, Viability, and Immunogenicity of Discarded Newly Diagnosed Glioblastoma Tissue or Solid Tumor Tissues
Analysis of Cell Count, Viability, and Immunogenicity of Deidentified Discarded Newly Diagnosed Glioblastoma Tissue and More Broadly Other Newly Diagnosed Solid Tumor Tissues From the Operating Room
Source: ClinicalTrials.gov · Last updated 10 Feb 2026
Brief summary (registry, in English)
This study examines tumor tissues and blood samples to aid in the development of therapies for brain cancer and other solid tumors. Studying samples of blood and tissue from patients with glioblastoma or other solid tumor in the laboratory may help doctors understand brain tumors and better inform future treatments.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 141 (actual)
- First submitted
- 4 Mar 2021
- Start date
- 3 Feb 2021
- Primary completion date
- 30 Jun 2025
- Lead sponsor
- Thomas Jefferson University
- Diseases
- Glioblastoma
- NCT number
- NCT04822688
What you commit to
- Study type: Observational
- Participants enrolled: 141
- From 3 Feb 2021 to the primary completion date, 30 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who are not surgical candidates
Age
- Individuals less than 18 years old
Other
- Unable to understand and give consent
Who the study is looking for
- Provide signed and dated informed consent form
- Any individual \>= 18 years old
- Patients must have GBM or other solid tumor and undergoing surgery for diagnostic and therapeutic purposes
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Thomas Jefferson University Hospital Coordinator of this site? Confirm its status | Philadelphia | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.